PRP guidelines · Indian

Leukocyte-Rich vs. Leukocyte-Poor Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis

Ashim Gupta, Madhan Jeyaraman and Anish G. Potty

Biomedicines · 2023

In brief

An editorial weighing leukocyte-rich against leukocyte-poor platelet-rich plasma (PRP) for knee osteoarthritis, drawing mainly on a randomised trial and a related meta-analysis. Both forms appeared to give similar improvement, so the authors view either as reasonable, while pointing to limitations of the evidence and calling for larger, longer blinded trials.

Read the original paper (opens in a new tab)

Citation, as listed in the PRP guidelines

Leukocyte-Rich vs. Leukocyte-Poor Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis Authors: Ashim Gupta, Madhan Jeyaraman and Anish G. Potty Link: https://www.mdpi.com/2227-9059/11/1/141 Year of Publication: 2023

A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.

More from the PRP guidelines

Ready to rewrite your health story?

Request a callback from our team.